BioStock interview with CEO Kjell Stenberg
May 28, 2024
Cyxone’s new CEO Kjell Stenberg gives his view on the company’s development projects, rabeximod for RA and T20K for MS, in this interview with BioStock (in Swedish).
Watch the interview here: https://cyxone.com/media/bolagspresentationer/